USP Part D model formulary guidelines
Executive Summary
U.S. Pharmacopeia plans to release a draft version of its Medicare Part D model formulary guidelines 4.0 for the 2009 benefit year on Nov. 6, 2007. Comments on the draft will be accepted until Dec. 31, 2007, and a final version is scheduled to be forwarded to CMS by Feb. 4, 2008. USP's model guidelines expert committee is scheduled to consider the 4.0 version in a closed meeting scheduled for Oct. 1. Comments on the guidelines and requests for revision are accepted by USP throughout the year. The guidelines are used by CMS as a framework for reviewing formulary submissions by Part D plans...
You may also be interested in...
Merck’s ‘COVID Pill’ Shows Promise, But Mortality Benefits Will Be Hard To Prove
Early results from its novel antiviral are encouraging, but demonstrating life-saving qualities in a short window of time will be tricky.
ROI For US With FDA's Emergency Use Approval Of Cue Health's OTC At-Home COVID-19 Test
After federal agencies invested almost $5600m to ensure Cue Health could scale up production, FDA announces the self-administered test will be available OTC. it's the agency's first emergency use authorization for an at-home molecular diagnostic test available nonprescription.
AstraZeneca & Amgen Seek EU Fast-Track For Severe Asthma Drug
Tezepelumab was among four products that the European Medicines Agency most recently considered for review under its accelerated assessment mechanism.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: